MEDNAX Inc
NYSE:MD
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.77
16.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
MD Price Targets Summary
MEDNAX Inc
According to Wall Street analysts, the average 1-year price target for MD is 15.89 USD with a low forecast of 13.13 USD and a high forecast of 18.9 USD.
MD Last Price Targets
MEDNAX Inc
The latest public price target was made on Oct 7, 2024 by David MacDonald from Truist Financial , who expects MD stock to drop by 13% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
David MacDonald
Truist Financial
|
13
USD
Downside 13% |
1 month ago
Oct 7, 2024
|
Pediatrix Medical price target raised to $13 from $10 at Truist
TheFly
|
Jack Slevin
Jefferies
|
14
USD
Downside 6% |
1 month ago
Sep 26, 2024
|
Jefferies Upgrades Pediatrix Medical Group (MD) to Buy
StreetInsider
|
David MacDonald
Truist Financial
|
10
USD
Downside 33% |
3 months ago
Aug 15, 2024
|
Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities
StreetInsider
|
Pito Chickering
Deutsche Bank
|
8
USD
Downside 47% |
5 months ago
Jun 7, 2024
|
Deutsche Bank Upgrades Pediatrix Medical Group (MD) to Hold
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MD's stock price target?
Price Target
15.89
USD
According to Wall Street analysts, the average 1-year price target for MD is 15.89 USD with a low forecast of 13.13 USD and a high forecast of 18.9 USD.
What is MEDNAX Inc's Revenue forecast?
Projected CAGR
1%
For the last 8 years the compound annual growth rate for MEDNAX Inc's revenue is -4%. The projected CAGR for the next 3 years is 1%.
What is MEDNAX Inc's Operating Income forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for MEDNAX Inc's operating income is -15%. The projected CAGR for the next 3 years is 7%.